Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children

Clinical Infectious Diseases

Volumn 31, Issue 5, 2000, Pages 1134-1138

  Frenck, Robert W ^a   Nakhla, Isabelle ^a   Sultan, Yehia ^b   Bassily, Samir B ^a   Girgis, Youssef F ^a   David, John ^a   Butler, Thomas C ^c   Girgis, Nabil I ^a   Morsy, Mosaad ^d  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b ABBASSIA FEVER HOSPITAL   (Egypt)

^c TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; CIPROFLOXACIN;

ADOLESCENT; ARTICLE; BLOOD CULTURE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SENSITIVITY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION PAIN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELAPSE; SALMONELLA TYPHI; TYPHOID FEVER;

ADOLESCENT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CEFTRIAXONE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; SALMONELLA TYPHI; TREATMENT OUTCOME; TYPHOID FEVER;

EID: 0034457248     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/317450     Document Type: Article

References (25)

1. Comparison of clinical features and pathologic findings in fatal cases of typhoid fever during the initial and later stages of the disease
2. Treatment of typhoid fever: Randomized trial of a three-day course of ceftriaxone versus a fourteen-day course of chloramphenicol
3. Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: A randomized clinical trial
4. Multi-drug resistant typhoid fever: A global problem
5. Quinolone-resistant Salmonella typhi in Vietnam: Molecular basis of resistance and clinical response to treatment
6. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children
7. Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone and other newer cephalosporins
8. In vitro activity of azithromycin (CP-62,993), a novel macrolide, against enteric pathogens
9. In vitro activity of azithromycin compared with other macrolides and oral antibiotics against Salmonella typhi
10. In vitro activity of azithromycin against bacterial enteric pathogens
11. Correlation of the extravascular pharmacokinetics of azithromycin with in-vivo efficacy in models of localized infection
12. Comparative efficacies of azithromycin and ciprofloxacin against experimental Salmonella typhimurium infection in mice
13. Distribution of orally administered azithromycin in various blood compartments
14. Efficacy ofazithromycin for typhoid fever
15. Azithromycin versus ciprofloxacin for the treatment of uncomplicated typhoid fever that included patients with multidrug resistance
16. Sample size nomograms for interpreting negative clinical studies
17. Escherichia, Salmonella, Shigella and Yersinia
18. Antibiotic susceptibility testing by a standardized single disk method
19. Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever
20. Ciprofloxacin versus ceftriaxone in the treatment of multiresistant typhoid fever
21. Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug resistant Salmonella typhi septicemia in children
22. Three-day treatment of typhoid fever with two different doses of ceftriaxone, compared to 14-day therapy with chloramphenicol: A randomized trial
23. A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children
24. Outcome in three groups of patients with typhoid fever in Indonesia between 1948 and 1990
25. Ciprofloxacin for treatment of severe typhoid fever in children